Lodestar Bio
Lodestar Bio is an engineering company focused on genomics, providing a second chance at diagnosis for individuals with inconclusive genomic tests. They offer a patient-controlled marketplace for rare disease genomic data. Their services include personal consultation, reinterpretation of existing genomic assays by leveraging their interpretation partners, and matching patients with potential new treatments based on re-analysis results. The company was founded in 2023 by Jessime Kirk (CEO) and Ben Schiller (CTO), who have extensive experience in bioinformatics and genomics companies. Lodestar aims to ensure that genomic data is fully utilized to develop treatments and cures for rare diseases, with a mission to provide every child with a rare disease a diagnosis.
Lodestar Bio
Lodestar Bio is an engineering company focused on genomics, providing a second chance at diagnosis for individuals with inconclusive genomic tests. They offer a patient-controlled marketplace for rare disease genomic data. Their services include personal consultation, reinterpretation of existing genomic assays by leveraging their interpretation partners, and matching patients with potential new treatments based on re-analysis results. The company was founded in 2023 by Jessime Kirk (CEO) and Ben Schiller (CTO), who have extensive experience in bioinformatics and genomics companies. Lodestar aims to ensure that genomic data is fully utilized to develop treatments and cures for rare diseases, with a mission to provide every child with a rare disease a diagnosis.